NorthInvest

my2be is an online mentoring platform designed to facilitate mentorship connections between individuals and organizations. By pairing experienced mentors with mentees, the platform aims to enhance employee retention and foster collaboration across diverse geographical and cultural backgrounds. Additionally, my2be connects businesses to a broader ecosystem, enabling them to achieve measurable social impact. The platform emphasizes the importance of mentorship in professional development, creating opportunities for growth and support within organizations.

Heatio is a developer of innovative home energy technology that focuses on providing affordable renewable energy solutions to homeowners. The company offers a pioneering approach to energy management through its platform, which functions as a virtual power plant. This technology allows for the optimization and control of connected systems and devices within the home, including heat pumps, electric batteries, and solar panels. By facilitating a roadmap for improvements, Heatio enables customers to enhance their energy efficiency, ultimately leading to significant savings on energy bills.

Molymem is a company focused on developing advanced membranes designed to improve the efficiency of separation processes, particularly in water treatment applications such as desalination and industrial contaminant removal. Their technology emphasizes the creation of membranes that offer high water permeance, selective species rejection, and resistance to corrosion. By addressing global water and wastewater challenges, Molymem aims to support industries and municipalities in minimizing their environmental impact and managing water resources more effectively.

BelleVie is a provider of personal care services aimed at supporting individuals in their daily lives while enabling them to maintain their independence. The company offers a range of services, including personal care, meal preparation, home assistance, social engagement, and specialized care. BelleVie operates with a unique model of self-managing teams, inspired by the successful Buurtzorg approach from the Netherlands, which emphasizes fulfilling careers in care and fosters meaningful relationships within the care ecosystem. The company utilizes its proprietary Wellbeing OS technology platform to facilitate its operations, funded through a monthly subscription model. BelleVie’s vision focuses on creating a society where every individual is valued and supported, ensuring that care providers and recipients alike benefit from reciprocal and enriching interactions.

Dyman Advanced Materials specializes in the development of a patented technology aimed at enhancing the manufacturing process of synthetic diamonds. This innovative approach seeks to improve the efficiency of the traditional high-pressure and high-temperature method used in diamond synthesis, resulting in reduced production costs. By providing a more economical production method, Dyman's technology serves both the industrial and gemstone market sectors, facilitating the broader availability of high-quality synthetic diamonds.

FourJaw Manufacturing Analytics is a provider of a machine-agnostic data analytics platform designed to enhance machining productivity through data-driven insights. The platform offers real-time visibility into shop floor operations, allowing users to monitor the status of each machine and identify unplanned downtime. By utilizing cloud-based technology, FourJaw enables small and medium-sized enterprises (SMEs) in the manufacturing sector to access critical analytics that support improved operational efficiency and productivity. Through its comprehensive approach, FourJaw aims to empower manufacturers with the tools necessary to optimize their processes and make informed decisions.

BIOStress is a company focused on enhancing the understanding and management of stress through innovative technology. It has developed a proprietary algorithm that accurately measures stress levels using data from existing biometric devices. By leveraging this technology, BIOStress offers a platform that objectively monitors workplace stress, providing employees with personalized insights into their stress levels. This approach not only aims to improve individual well-being but also enhances overall productivity within organizations. By focusing on the balance between well-being and stress management, BIOStress seeks to foster healthier work environments and better performance outcomes.

Diode is a company focused on facilitating the transition to electric vehicles and net zero products for businesses. It provides electric vehicle suitability assessments, infrastructure recommendations, and charge point procurement services tailored to various business needs. Additionally, Diode operates a sales enablement platform designed to help consumers adopt sustainable products through engaging digital experiences and personalized survey tools. This platform enhances customer engagement and retention by delivering tailored recommendations, ultimately driving sales growth and improving customer satisfaction. Through its innovative approach, Diode aims to support businesses in navigating the shift towards energy-efficient technologies and contribute to the broader adoption of sustainable practices.

Dyman Advanced Materials specializes in the development of a patented technology aimed at enhancing the manufacturing process of synthetic diamonds. This innovative approach seeks to improve the efficiency of the traditional high-pressure and high-temperature method used in diamond synthesis, resulting in reduced production costs. By providing a more economical production method, Dyman's technology serves both the industrial and gemstone market sectors, facilitating the broader availability of high-quality synthetic diamonds.

C-Link is an online platform designed to enhance the subcontract procurement process for developers and main contractors. The platform provides access to a network of prequalified subcontractors, along with tools for tender analysis and contract management. By simplifying these procurement tasks, C-Link enables small and medium-sized enterprises to operate efficiently and maintain agility, while achieving the benefits typically associated with larger supply chain teams. Through its services, C-Link supports users in effectively managing the procurement phase of construction projects.

Evince Technology is a UK-based start-up focused on developing innovative electron devices for various industries, including metrology, healthcare, communications, and advanced manufacturing. The company has created a new type of solid-state switch that aims to transform the high-frequency electronics sector. Its technology leverages synthetic diamonds to enhance the performance of these devices through thermionic valves, which utilize the exceptional thermal and electronic properties of diamonds. This advancement positions Evince as a key player in providing efficient solutions for effective electrical energy control, catering to the needs of developers and manufacturing partners.

Dyman Advanced Materials specializes in the development of a patented technology aimed at enhancing the manufacturing process of synthetic diamonds. This innovative approach seeks to improve the efficiency of the traditional high-pressure and high-temperature method used in diamond synthesis, resulting in reduced production costs. By providing a more economical production method, Dyman's technology serves both the industrial and gemstone market sectors, facilitating the broader availability of high-quality synthetic diamonds.

Renephra Ltd. is a medical device company based in Manchester, United Kingdom, established in 2009. It specializes in developing innovative Transdermal Fluid Removal (TFR) technology aimed at addressing fluid overload and chronic conditions such as oedema and lymphoedema. The company's devices utilize a micro-needle system combined with negative pressure therapy to facilitate minimally invasive fluid removal from the skin. This technology targets significant clinical needs within vascular and oncology patients, representing a large and underserved market estimated at £1 billion globally. Having achieved proof of concept in human trials, Renephra is currently seeking funding to advance its device development and feasibility studies.